Post–herpes simplex virus encephalitis relapses have been recently associated with autoimmunity driven by autoantibodies against N-methyl-d-aspartate (NMDA) receptors. Because it offers different treatment options, determination of this condition is important. Between 2011 and 2014, 7 children with proven diagnosis of herpes simplex virus encephalitis were identified in a university hospital of Istanbul. Two patients had neurologic relapse characterized mainly by movement disorders 2 to 3 weeks after initial encephalitis. The first patient received a second 14 days of acyclovir treatment together with antiepileptic drugs and left with severe neurologic sequelae. The second patient was found to be NMDA receptors antibody positive in the cerebrospinal fluid. She was treated with intravenous immunoglobulin and prednisolone. She showed substantial improvement, gradually regaining lost neurologic abilities. Post–herpes simplex virus encephalitis relapses may frequently be immune-mediated rather than a viral reactivation, particularly in children displaying movement disorders like choreoathetosis. Immunotherapy may provide benefit for this potentially devastating condition, like the case described in this report.
GlaserCAGilliamSSchnurrD. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis. 2003;36:731–742.
2.
HjalmarssonABlomqvistPSkoldenbergB. Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis. 2007;45:875–880.
3.
TylerKL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes. 2004;11(suppl 2):57A–64A.
4.
StahlJPMaillesADe BrouckerT. Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol Infect. 2012;140:372–381.
5.
SkoldenbergBAureliusEHjalmarssonA. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol. 2006;253:163–170.
6.
De TiegeXRozenbergFPortes DesV. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology. 2003;61:241–243.
7.
KullnatMWMorseRP. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics. 2008;121: e1003–e1007.
8.
LimMMensonETongCYLinJP. Use of therapeutic drug monitoring in the long-term valacyclovir therapy of relapsing herpes simplex virus encephalitis in children. J Antimicrob Chemother. 2009;64:1340–1341.
9.
DalmauJTuzunEWuHY. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.
10.
GleichmanAJSpruceLADalmauJ. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci. 2012;32:11082–11094.
11.
DalmauJLancasterEMartinez-HernandezE. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.
12.
PrussHFinkeCHoltjeM. N-Methyl-d-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012;72:902e11.
13.
ArmangueTTitulaerMJMálagaI. Pediatric anti-N-methyl-d-aspartate receptor encephalitis—clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013;162:850–856.
WickströmRFowlerACoorayG. Viral triggering of anti-NMDA receptor encephalitis in a child—an important cause for disease relapse. Eur J Paediatr Neurol. 2014;18:543–546.
16.
ArmangueTLeypoldtFMálagaI. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014;75:317–323.
17.
DesenaAGravesDWarnackWGreenbergBM. Herpes simplex encephalitis as a potential cause of anti-N-methyl-d-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol. 2014;71:344–346.
18.
MohammadSSSinclairKPillaiS. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-methyl-d-aspartate receptor or dopamine-2 receptor. Mov Disord. 2014;29:117–122.
SkoldenbergBAureliusEHjalmarssonA. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol. 2006;253:163–170.
21.
AbramsonJSRoachESLevyHB. Postinfectious encephalopathy after treatment of herpes simplex encephalitis with acyclovir. Pediatr Infect Dis. 1984;3:146–147.
